MHRA Drug Safety Update July 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on:

  • Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia.
  • Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine.
  • Letters and medicine recalls sent to healthcare professionals in June 2023.

To see the latest MHRA Drug Safety Updates in full, visit the website.